We’re committed to improving the IVF process through chromosome screening. We believe making informed choices about a family’s reproductive health starts with preimplantation genetic screening. PGS helps patients gain better outcomes and aim to reshape the IVF process as we know it.
With multiple scientific publications from key leaders in the field, we’ve proven the strength and reliability of our technology for chromosome screening and are dedicated to providing both education and resources to improve patient access.
Samples are biopsied locally at the IVF clinic.
Chromosome screening is performed at a specialized genetic testing laboratory.
Couples do not need to travel to the testing site, but can be kept informed by their chosen IVF clinic.
Illumina is committed to providing comprehensive solutions and to being a trusted partner to our customers across the reproductive health continuum. PGS and PGD solutions are at the forefront of this continuum and we aim to reshape the IVF process as we know it. With a world-class community of users, Illumina is a leader in the industry, driving the evolution of innovative applications of genetic technology in reproductive health.
From library prep, arrays, and sequencing to informatics, Illumina next-generation solutions empower researchers and clinicians across the globe to find the answers they seek.
We’re here with all the resources you need to accelerate progress. In addition to onsite training, ongoing support, and phone consults, we offer webinars and courses around the world.